Imad Asaad

408 total citations
29 papers, 274 citations indexed

About

Imad Asaad is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Imad Asaad has authored 29 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 13 papers in Surgery and 10 papers in Hepatology. Recurrent topics in Imad Asaad's work include Liver Disease Diagnosis and Treatment (20 papers), Diet, Metabolism, and Disease (7 papers) and Pancreatitis Pathology and Treatment (6 papers). Imad Asaad is often cited by papers focused on Liver Disease Diagnosis and Treatment (20 papers), Diet, Metabolism, and Disease (7 papers) and Pancreatitis Pathology and Treatment (6 papers). Imad Asaad collaborates with scholars based in United States, Lebanon and Barbados. Imad Asaad's co-authors include Sara Ghoneim, Aun R. Shah, Antoine Boustany, Naim Alkhouri, Mazen Noureddin, Phuc Le, Almaza A. Albakri, Miriam B. Vos, Chang H. Kim and Nicholas C. Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Imad Asaad

23 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Imad Asaad United States 8 203 75 71 63 54 29 274
Θεόδωρος Ανδρουτσάκος Greece 10 239 1.2× 145 1.9× 123 1.7× 64 1.0× 46 0.9× 36 390
Tae Hun Kim South Korea 11 128 0.6× 75 1.0× 26 0.4× 44 0.7× 18 0.3× 28 296
Marianthi Papagianni Greece 9 161 0.8× 35 0.5× 46 0.6× 49 0.8× 10 0.2× 18 244
Tomomi Okubo Japan 13 238 1.2× 190 2.5× 80 1.1× 46 0.7× 27 0.5× 39 364
Aunchalee Jaroenlapnopparat United States 9 90 0.4× 27 0.4× 39 0.5× 75 1.2× 16 0.3× 36 247
Laura Iogna Prat United Kingdom 12 228 1.1× 158 2.1× 52 0.7× 55 0.9× 12 0.2× 23 284
Haak Cheoul Kim South Korea 8 82 0.4× 68 0.9× 26 0.4× 41 0.7× 29 0.5× 14 163
Savio John United States 9 151 0.7× 159 2.1× 20 0.3× 141 2.2× 29 0.5× 37 345
Nicholas Manton Australia 8 145 0.7× 43 0.6× 89 1.3× 55 0.9× 6 0.1× 15 269
Chander K. Nain India 11 215 1.1× 136 1.8× 24 0.3× 165 2.6× 12 0.2× 14 386

Countries citing papers authored by Imad Asaad

Since Specialization
Citations

This map shows the geographic impact of Imad Asaad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imad Asaad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imad Asaad more than expected).

Fields of papers citing papers by Imad Asaad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imad Asaad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imad Asaad. The network helps show where Imad Asaad may publish in the future.

Co-authorship network of co-authors of Imad Asaad

This figure shows the co-authorship network connecting the top 25 collaborators of Imad Asaad. A scholar is included among the top collaborators of Imad Asaad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imad Asaad. Imad Asaad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dunn, Winston, Ashwani K. Singal, Imad Asaad, et al.. (2025). OS-097 Evaluating noninvasive diagnostic pathways for identifying MASH patients eligible for Resmetirom therapy: a real-world cohort analysis. Journal of Hepatology. 82. S66–S66.
2.
Singal, Ashwani K., Imad Asaad, Edward Mena, et al.. (2025). SAT-438 General characteristics of the patients prescribed Resmetirom: data derived from six tertiary care centers in the United States. Journal of Hepatology. 82. S634–S635.
3.
4.
5.
Boustany, Antoine, et al.. (2023). ANTIDEPRESSANT MEDICATIONS ARE ASSOCIATED WITH INCREASED RISK OF HOSPITAL-ACQUIRED CLOSTRIDIOIDES DIFFICILE INFECTION: A POPULATION-BASED STUDY. Arquivos de Gastroenterologia. 60(3). 309–314. 2 indexed citations
6.
Boustany, Antoine, et al.. (2023). Increased Risk of Non-Alcoholic Steatohepatitis in Patients With Inflammatory Bowel Disease: A Population-Based Study. Cureus. 15(3). e35854–e35854. 7 indexed citations
7.
Boustany, Antoine, et al.. (2023). Non‐alcoholic steatohepatitis is independently associated with a history of gestational diabetes mellitus. Journal of Gastroenterology and Hepatology. 38(6). 984–988. 6 indexed citations
8.
9.
Boustany, Antoine, et al.. (2023). Prevalence of non-alcoholic fatty liver disease in patients with nephrotic syndrome: A population-based study. World Journal of Hepatology. 15(2). 265–273. 5 indexed citations
10.
Boustany, Antoine, et al.. (2023). Increased Risk of Colorectal Cancer in Patients With Celiac Disease: A Population-Based Study. Cureus. 15(3). e36964–e36964. 2 indexed citations
11.
Asaad, Imad, et al.. (2022). The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study. Annals of Hepatology. 27(5). 100727–100727. 52 indexed citations
12.
13.
14.
Kumar, Prabhat, et al.. (2022). S1257 Smoking Increases the Risk for Cirrhosis and Esophageal Varices Among Patients With Non-Alcoholic Fatty Liver Disease. The American Journal of Gastroenterology. 117(10S). e907–e907.
15.
Alkhayyat, Motasem, et al.. (2022). Prevalence of hypothyroidism and effect of thyroid hormone replacement therapy in patients with non-alcoholic fatty liver disease: A population-based study. World Journal of Hepatology. 14(3). 551–558. 8 indexed citations
16.
Ghoneim, Sara, et al.. (2020). The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study. SHILAP Revista de lepidopterología. 8. 100057–100057. 56 indexed citations
17.
Ghoneim, Sara, et al.. (2020). FIB-4 Regression With Direct-Acting Antiviral Therapy in Patients With Hepatitis C Infection: A Safety-Net Hospital Experience. Frontiers in Medicine. 7. 359–359. 5 indexed citations
18.
Ghoneim, Sara, et al.. (2020). Non-alcoholic steatohepatitis and the risk of myocardial infarction: A population-based national study. World Journal of Hepatology. 12(7). 378–388. 13 indexed citations
19.
Ghoneim, Sara, et al.. (2020). S1059 The Incidence of COVID-19 in Patients With Metabolic Syndrome and Non-Alcoholic Steatohepatitis: A Population-Based Study. The American Journal of Gastroenterology. 115(1). S537–S537. 14 indexed citations
20.
Khoudari, George, Amandeep Singh, Mazen Noureddin, et al.. (2019). Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort. World Journal of Hepatology. 11(10). 710–718. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Θεόδωρος Ανδρουτσάκος Breakdown of academic impact, for papers by Tae Hun Kim Breakdown of academic impact, for papers by Marianthi Papagianni Breakdown of academic impact, for papers by Tomomi Okubo Breakdown of academic impact, for papers by Aunchalee Jaroenlapnopparat Breakdown of academic impact, for papers by Laura Iogna Prat Breakdown of academic impact, for papers by Haak Cheoul Kim Breakdown of academic impact, for papers by Savio John Breakdown of academic impact, for papers by Nicholas Manton Breakdown of academic impact, for papers by Chander K. Nain
Rankless by CCL
2026